期刊文献+

大鼠尿毒症血清对体外培养血管内皮细胞损伤作用研究

In Vitro Injury Effects of Sera of Rats with Uremia on Vasular Endothelial Cells
原文传递
导出
摘要 目的:研究大鼠尿毒症血清干预对人脐静脉内皮细胞(HUVEC)的作用及临床意义。方法:将20只SD大鼠随机分为健康组(假手术组)和尿毒症12周组。对尿毒症组大鼠进行5/6肾切除,致其慢性肾衰。以不同体积分数(10%、15%、20%、25%)的尿毒症和健康大鼠血清处理HUVEC 24h,显微镜下观察HUVEC形态改变,MTT法测细胞活力,TBA法测胞浆丙二醛含量,RT-PCR法测定IL-6、TNF-α、NF-κB、Caspase-3mRNA相对表达量。结果:尿毒症环境能使细胞活力降低,使细胞内MDA、IL-6、TNF-α、NF-κB、Caspase-3含量呈浓度依赖性上升。结论:尿毒症血清促进血管内皮微炎症状态的形成,引起血管内皮细胞氧化损伤,促进血管内皮细胞的凋亡。提示尿毒症患者长期处于慢性炎症状态,心血管疾病的发病风险较高。 Objective:To investigate the in vitro injury effects of sera of rats with uremia on vasular endothelial cells,and explore their clinical significance.Methods:Twenty SD rats were randomly devided into healthy group(sham-operated group) and 5/6 nephrectomy(5/6 NX) for 12 weeks.The chronic renal failure models were established on rats by 5/6 NX.Human umbilical vascular endothelial cells(HUVEC) were treated with sera of rats with uremia and healthy rats of different volume fractions(10%、15%、20%、25%).The cell morphology was observed by immunohistochemical staining;Cell viability was assessed by measuring their ability to metabolize the MTT salt;and Real-Time PCR was employed to detect the expression of IL-6,TNF-α,NF-κB,Caspase-3 mRNA in cells.Results:Compared with healthy serum group,MDA was increased significantly,the expression of IL-6、TNF-α、NF-κB and Caspase-3 mRNA in HUVEC increased in uremic setum group.Conclusion:Treatment with sera of rats with uremia may change the morphology,inhibit the proliferation,promote the apoptosis,enhance the secretion of IL-6、TNF-α、NF-κB and Caspase-3 and lead to the dysfunction of vascular endothelial cells.Patients with uremia are under chromic inflammatory state in a long term,and have a greater risk of developing cardiovasular diseases.
机构地区 中国药科大学
出处 《亚太传统医药》 2013年第8期6-9,共4页 Asia-Pacific Traditional Medicine
关键词 尿毒症 5 6肾切除 人脐静脉内皮细胞 炎症 细胞凋亡 Uremia 5/6 NX HUVEC Inflammatory Apoptosis
  • 相关文献

参考文献10

  • 1梁敏,侯凡凡,刘志强,王力,田建伟.终末期肾病患者脂质过氧化水平的变化[J].肾脏病与透析肾移植杂志,2003,12(4):324-326. 被引量:8
  • 2REIS KA, GUZ G, OZDEMIR H, et al. Intravenous iron therapy as a possible risk factor for atheroselerosis in end- stage renal diease[J]. Int Heart J,2005,46(2) :255-264.
  • 3DURSUN E, DURSUN B, SULEYMANLAR G, et al. Effect of haemodialysis on the oxidative stress and antioxida nts in diabetes mellitus[J]. Acta Diabetol,2005,42 : 123-128.
  • 4DANIELSKI M, IKIZLER TA, MCMONAGLE E, et al. Linkage of hypolbuminemia, inflammation, and oxidative stress in patients receive maintenance hemodialysis therapy [J]. Am J Kidney Dis,2003,42:286-294.
  • 5李聪,郝旭,周桥,卢颖,王伟铭,陈楠.尿毒症患者血清对体外培养的血管内皮细胞的损伤作用[J].上海交通大学学报(医学版),2011,31(7):900-904. 被引量:6
  • 6李小丽,甘华,常晓东,杜晓刚.尿毒症患者血清对内皮细胞凋亡的影响及rhEPO的干预作用[J].第三军医大学学报,2009,31(22):2255-2257. 被引量:3
  • 7ALLEN AC, TOPHAM PS, HARPER SJ, et al. Leucocyte ~1,3 galactosyl transferasc activity in IgA Nephropathy[J]. Nephrol Dial Transplant ,1997,12(8):701 706.
  • 8VITA JA, KEANEY JF JR. Endothelial function: a baromiter for eardio vascular risk [J]. Circulation, 2002, 106 ( 6 ) : 640- 642.
  • 9NANAYAKKARA P W B, GAILLARD C A J M. Vascular disease and chronic renal {ailure= new insights[J]. Neth J Med,2010,68(1) =5-14.
  • 10YONOVA D. Vascular calcification and metabolic acidosis in end stage renal disease[J]. Hippokratia,2009,13(3):139-140.

二级参考文献34

  • 1Tedgui A, Mallat Z. Apoptosis, a major determinant of atherothrombosis[J]. ArchMalCoeurVaiss, 2003, 96(6):671 -675.
  • 2Ehrenreieh H, Aust C, Krampe H, et al. Erythropoielin: novel approaches to neuroproteetion in human brain disease [ J ]. Metab Brain Dis, 2004, 19(3 -4) : 195 -206.
  • 3Moon C, Krawczyk M, Paik D, et al. Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window [ J ]. Cardiovasc Drugs Ther, 2005, 19(4) : 243 -250.
  • 4Imamura R, Isaka Y, Ichimaru N, et al. Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis [ J ]. Biochem Biophys Res Commun, 2007, 353 (3) : 786 -792.
  • 5Szezepanski M, Kamianowska M, Wnuczko K, et al. Erythropoietin prevents oxidative stress and lipid peroxidation process in human umbilical vein endothelial cells induced by tumor necrosis factor alpha [ J]. Pol Merkur Lekarski, 2006, 21 (126): 534- 539.
  • 6Schiffrin E L, Lipman M L, Mann J F. Chronic kidney disease: effects on the cardiovascular system [ J ]. Circulation, 2007, 116 ( 1 ) : 85 - 97.
  • 7Go A S, Chertow G M, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization[J]. N Engl J Med, 2004, 351(13): 1296-1305.
  • 8Nakagami H, Kaneda Y, Ogihara T, et al. Endothelial dysfunction in hyperglycemia as a trigger of athernsclerosis [ J]. Curr Diabetes Rev, 2005, 1(1): 59-63.
  • 9Carbo C, Arderiu G, Escolar G, et al. Differential expression of proteins from cultured endothelial ceils exposed to uremic versus normal serum[J]. Am J Kidney Dis, 2008, 51(4) : 603 -612.
  • 10Ayus J C, Go A S, Valderrabano F, et al. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin < 10 g/dL[J]. Kidney Int, 2005,68(2) : 788 -795.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部